Skip to main content
Figure 1 | Critical Care

Figure 1

From: Circulating soluble urokinase plasminogen activator receptor is stably elevated during the first week of treatment in the intensive care unit and predicts mortality in critically ill patients

Figure 1

Serum suPAR concentrations in critically ill patients with different disease etiologies at ICU admission. (A) At admission to the Medical ICU, serum suPAR levels were significantly (P < 0.001, U-test) elevated in critically ill patients (n = 273) as compared to healthy controls (n = 43). (B) In comparison to ICU patients without SIRS or with SIRS, septic patients had higher suPAR serum concentrations (U-tests to sepsis group, P-values given in figure). (C) suPAR serum concentrations did not differ in patients with either pulmonary or non-pulmonary origin of sepsis and are highest in patients with decompensated liver cirrhosis.

Back to article page